Contact
searchSearch
HMP Global
Login

Advertisement

ADVERTISEMENT

Conference Coverage

Conference Coverage
Clinical Implications of Tumor-Based Next-generation Sequencing in Ovarian Cancer
06/04/2022
A study presented at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting assessed the clinical relevance of tumor-based next-generation sequencing (tbNGS) in a large cohort of patients with high-grade epithelial ovarian...
A study presented at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting assessed the clinical relevance of tumor-based next-generation sequencing (tbNGS) in a large cohort of patients with high-grade epithelial ovarian...
A study presented at the 2022...
06/04/2022
Journal of Clinical Pathways
Conference Coverage
Real-World Utilization and Comparative Effectiveness of Treatment Options for Cancer–Associated Venous Thromboembolism
06/04/2022
In the real-world setting, patients with cancer–associated venous thromboembolism remain on anticoagulation for a short period of time and DOACs and warfarin may be associated with better compliance than low molecular weight heparin.
In the real-world setting, patients with cancer–associated venous thromboembolism remain on anticoagulation for a short period of time and DOACs and warfarin may be associated with better compliance than low molecular weight heparin.
In the real-world setting,...
06/04/2022
Journal of Clinical Pathways
Conference Coverage
Pharmacist Interventions in Oral Oncolytics Program Shown to Provide Cost Savings
06/04/2022
A study presented at the 2022 ASCO Annual Meeting shows that pharmacist interventions in the Pharmacist-Managed Oral Chemotherapy Clinic at Kaiser Permanente San Diego led to significant overall cost savings to the health care system.
A study presented at the 2022 ASCO Annual Meeting shows that pharmacist interventions in the Pharmacist-Managed Oral Chemotherapy Clinic at Kaiser Permanente San Diego led to significant overall cost savings to the health care system.
A study presented at the 2022...
06/04/2022
Journal of Clinical Pathways

Advertisement

Conference Coverage
Bendamustine Plus Rituximab Among Older Patients With Newly Diagnosed Mantle Cell Lymphoma
06/04/2022
Research presented at ASCO demonstrates that ibrutinib, when combined with bendamustine-rituximab, improved progression-free survival by 50% for older patients with newly diagnosed mantle cell lymphoma.
Research presented at ASCO demonstrates that ibrutinib, when combined with bendamustine-rituximab, improved progression-free survival by 50% for older patients with newly diagnosed mantle cell lymphoma.
Research presented at ASCO...
06/04/2022
Journal of Clinical Pathways
Conference Coverage
Real-World Treatment Patterns in US Veterans With Nonmetastatic Castration–Resistant Prostate Cancer
06/03/2022
Despite the recent approval of several nmCRPC treatments that have demonstrated improved metastasis-free survival and quality of life, first-generation antiandrogens remain the predominant first-line treatment among these patients.
Despite the recent approval of several nmCRPC treatments that have demonstrated improved metastasis-free survival and quality of life, first-generation antiandrogens remain the predominant first-line treatment among these patients.
Despite the recent approval of...
06/03/2022
Journal of Clinical Pathways
Conference Coverage
Financial Impact of Switching From Abiraterone to Generic Therapeutics for Patients With Prostate Cancer in the Oncology Care Model
06/03/2022
Therapeutic interchange from brand name to generic abiraterone in The US Oncology Network generated significant savings for the Oncology Care Model, according to a study presented at the 2022 ASCO Annual Meeting.
Therapeutic interchange from brand name to generic abiraterone in The US Oncology Network generated significant savings for the Oncology Care Model, according to a study presented at the 2022 ASCO Annual Meeting.
Therapeutic interchange from...
06/03/2022
Journal of Clinical Pathways

Advertisement

Conference Coverage
Oncologist vs Urologist Treatment Decision-Making for Metastatic Castration–Sensitive Prostate Cancer in the United States
06/03/2022
Study findings presented at the 2022 ASCO Annual Meeting reveal oncologists’ and urologists’ reasons for underutilization of treatment intensification for patients with metastatic castration–sensitive prostate cancer.
Study findings presented at the 2022 ASCO Annual Meeting reveal oncologists’ and urologists’ reasons for underutilization of treatment intensification for patients with metastatic castration–sensitive prostate cancer.
Study findings presented at the...
06/03/2022
Journal of Clinical Pathways
Conference Coverage
Praise, Challenges, and Outcomes of The Oncology Medical Home Certification Pilot
03/31/2022
A panel at the 2022 Community Oncology Conference discussed the building and implementation of the ASCO and COA Oncology Medical Home Model, touching on its quality, outcomes, and value in cancer care.
A panel at the 2022 Community Oncology Conference discussed the building and implementation of the ASCO and COA Oncology Medical Home Model, touching on its quality, outcomes, and value in cancer care.
A panel at the 2022 Community...
03/31/2022
Journal of Clinical Pathways
Conference Coverage
Moving the Needle on Comprehensive Genomic Profiling
03/30/2022
In a session at the 2022 Community Oncology Conference, experts convened to discuss the current landscape of comprehensive genomic profiling in the United States.
In a session at the 2022 Community Oncology Conference, experts convened to discuss the current landscape of comprehensive genomic profiling in the United States.
In a session at the 2022...
03/30/2022
Journal of Clinical Pathways

Advertisement

Conference Coverage
Addressing Disparities in Cancer Health, Equity, and Outcomes
03/29/2022
A panel at the 2022 Community Oncology Conference discussed how their programs address disparities in cancer care and access to cancer care.
A panel at the 2022 Community Oncology Conference discussed how their programs address disparities in cancer care and access to cancer care.
A panel at the 2022 Community...
03/29/2022
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

JCP September/October 2024 Issue

Current Issue

October 2024
Volume 10
Issue 5
Current Issue
Issue Archive

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Special Reports

JCP Special Report
Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group
05/20/2022
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways...
05/20/2022
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement

Advertisement

Subscribe

Journal of Clinical Pathways Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use